Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy
- 1 March 2004
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 94 (1) , 93-97
- https://doi.org/10.1016/j.ijcard.2003.05.008
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- No effect on central or peripheral blood pressure of systemic urotensin II infusion in humansBritish Journal of Clinical Pharmacology, 2002
- High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in manCardiovascular Research, 2002
- Urotensin II evokes potent vasoconstriction in humans in vivoBritish Journal of Pharmacology, 2002
- Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissuesJournal Of Hypertension, 2001
- Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferationJournal Of Hypertension, 2001
- Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal ratsFEBS Letters, 2001
- Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells.Circulation, 2001
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature, 1999
- Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstrictionNature Cell Biology, 1999
- Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cordProceedings of the National Academy of Sciences, 1998